| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 07/19/2006 | EP1680420A2 Compounds, compositions, and methods |
| 07/19/2006 | EP1680137A2 Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of hcv replication |
| 07/19/2006 | EP0996447B1 Combination therapy for modulating the human sexual response |
| 07/19/2006 | CN1805964A 1.3.4-triaza-phenalene and 1,3,4,6-tetraazaphenalene derivatives |
| 07/19/2006 | CN1805963A Cannabinoid receptor ligands and uses thereof |
| 07/19/2006 | CN1805959A Cycloalkanepyrrolopyridines as DP receptor antagonists |
| 07/19/2006 | CN1805958A Condensed N-heterocyclic compounds and their use as CRF receptor antagonists |
| 07/19/2006 | CN1805937A N-[(piperazinyl)hetaryl]arylsulfonamide compounds with affinity for the dopamine D3 receptor. |
| 07/19/2006 | CN1805686A Mitotic kinesin inhibitors |
| 07/19/2006 | CN1264846C Bicyclic pyrrolyl amides as glucogen phosphorylase inhibitors |
| 07/19/2006 | CN1264844C 4-amino-5-phenyl-7-cyclobutyl-pyrrolo (2,3-D) pyrimidie derivatives |
| 07/19/2006 | CN1264843C Pyrazolopgrimidinone derivatives having PED 7 inhibitory activity |
| 07/19/2006 | CN1264574C Oral preparations |
| 07/18/2006 | USRE39197 diaryl sulfides, substituted with cinnamides, such as (2,4-Dichlorophenyl)[2-(E-((6-hydroxyhexylamino)carbonyl)ethenyl)phenyl]sulfide, used for treating inflammatory and immune diseases in mammals |
| 07/18/2006 | US7078535 Method for the production of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-ylacetic acid |
| 07/18/2006 | US7078525 Antiproliferative agents; anticancer agents; antiinflammatroy agents; Alzheimer's disease; viricides; fungicides |
| 07/18/2006 | US7078427 Bioavailability; anticancer agents; viricides |
| 07/18/2006 | US7078420 Spiro-hydantoin compounds useful as anti-inflammatory agents |
| 07/18/2006 | US7078408 administering pyrimidinotriazole derivatives for improving motor impairment due to Parkinson's Disease |
| 07/18/2006 | US7078405 Psychological disorders; anxiolytic agents; dietetics; autoimmune diseases; antidepressants |
| 07/18/2006 | US7078401 "PGI2-preferring" (IP) receptors; p-(imidazolin-2-ylamino-optional alkyl)phenyl p'-substituted ethers or sulfides, e.g., 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-phenylsulfanyl)-phenyl]-amine, used to induce hyperalgesia |
| 07/18/2006 | US7078020 Heating antipsychotic drug to vaporize; cooling to form condensation aerosol; kit for dispensing thin coating |
| 07/18/2006 | US7078019 Heating a drug ester to vaporize; cooling to form condensation aerosol; drug delivery kit for dispensing thin coatings |
| 07/18/2006 | US7078018 Aerosol therapy; heating, vaporization, cooling, condensation; analgesics; alcoholism |
| 07/18/2006 | US7078017 Delivery of sedative-hypnotics through an inhalation route |
| 07/18/2006 | US7078014 In vivo magnetic resonance imaging by intravenous injection of compounds such as porphyrins, chlorins, bacteriochlorins, and related tetra- pyrrolic compounds with radioactive elements such as Technetium99, Gadolinium, Indium111 and iodine |
| 07/18/2006 | US7077896 Pigment composition and use thereof in plastic |
| 07/18/2006 | CA2356320C Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/13/2006 | WO2006073938A2 Method for the synthesis of 3-substituted indolizine and benzoindolizine compounds |
| 07/13/2006 | WO2006073610A2 Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them |
| 07/13/2006 | WO2006073167A1 Pyrrolidine derivatives |
| 07/13/2006 | WO2006072831A1 Pyrrolopyrazoles, potent kinase inhibitors |
| 07/13/2006 | WO2006072785A2 Base stable ionic liquids |
| 07/13/2006 | WO2006030977A3 Imidazole derivatives as large conductance calcium-activated k channel openers |
| 07/13/2006 | WO2006013095A3 Condensed pyridines as kinase inhibitors |
| 07/13/2006 | WO2006004833A3 Pyrrolotriazine kinase inhibitors |
| 07/13/2006 | WO2005123087A3 C-purine nucleoside analogs as inhibitors of rna-dependent rna viral polymerase |
| 07/13/2006 | US20060155126 Bicyclic heterocycles as cannabinoid receptor modulators |
| 07/13/2006 | US20060155125 Synthetic process |
| 07/13/2006 | US20060155124 Amphoteric fluorescent whitening agents |
| 07/13/2006 | US20060154967 e.g. [2-methyl-5-trifluoromethyl-2H-1,2,3-triazole-4-carboxylic acid methyl ester; fungicide; against the phytopathogenic fungi: Fungi imperfecti (Botrytis, Pyricularia, Helminthosporium), Basidiomycetes (Rhizoctonia, Hemileia), Ascomycetes classes (Venturia, Erysiphe), Oomycetes classes (Phytophthora) |
| 07/13/2006 | US20060154940 Reacting 4-Chloro-1-(2-fluoro-4-methanesulfonyl-phenyl)-1H-pyrazolo[3,4-d]pyrimidine with 4-hydroxy-piperidine-1-carboxylic acid isopropyl ester in presence of triphenylphosphine and Diisopropyl azodicarboxylate; modulators of glucose metabolism, therapy of metabolic disorder, diabetes and obesity |
| 07/13/2006 | US20060154930 Substituted amino heterocycles as vr-1 antagonists for treating pain |
| 07/13/2006 | US20060154929 Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds |
| 07/13/2006 | US20060154920 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij] quinoline derivatives as antipsychotic and antiobesity agents |
| 07/13/2006 | US20060154916 Condensed azepines as vasopressin agonists |
| 07/13/2006 | US20060154254 Rotaxane compound, rotaxane-bonded solid substrate, and biochip using the same |
| 07/13/2006 | US20060154105 Nitrogenous heterocyclic derivative and organic elecrtroluminescent element employing the same |
| 07/13/2006 | US20060153779 Rapidly producing peak plasma concentration; condensation aerosol containing ephedrine and/or fenfluramine; vaporization without degradation |
| 07/13/2006 | CA2593266A1 Aryl piperazine derivatives for the treatment of neuropsychiatric disorders |
| 07/13/2006 | CA2593049A1 Anti-tumor compounds |
| 07/13/2006 | CA2592007A1 Triazolophthalazines |
| 07/13/2006 | CA2591991A1 Triazolophthalazines |
| 07/13/2006 | CA2588627A1 Novel bicyclic heterocyclic compounds, process for their preparation and compositions containing them |
| 07/12/2006 | EP1678182A1 Process for preparing substituted 5-amino-pyrazolo- [4,3-e]-1,2,4-triazolo [1,5-c]pyrimidines |
| 07/12/2006 | EP1678181A2 A2b adenosine receptor antagonists |
| 07/12/2006 | EP1678180A1 Substituted 2h- 1,2,4 triazolo 4,3-a pyrazines as gsk-3 inhibitors |
| 07/12/2006 | EP1678173A2 4-heterobicyclylamino-substituted quinazolines and analogues thereof as capsaicin-antagonists |
| 07/12/2006 | EP1678166A2 Protein kinase inhibitors |
| 07/12/2006 | EP1678157A2 Heterocyclic compounds and methods of making and using thereof |
| 07/12/2006 | EP1677799A1 Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain |
| 07/12/2006 | EP1504009B1 Fungicidal triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing said fungicidal triazolopyrimidines |
| 07/12/2006 | EP1430055B1 7-tert-butyl-3-(2-fluorophenyl)-6-(2h-¬1,2,4|triazol-3-ylmethoxy)-¬1,2,4|triazolo¬4,3-b|pyridazine for the treatment of anxiety and convulsions |
| 07/12/2006 | EP1427732B1 Spirocyclic-6,7-dihydro-5h-pyrazolo 1,2-a|pyrazol-1-ones which control inflammatory cytokines |
| 07/12/2006 | EP1427730B1 Novel dihydropteridinones, method for producing the same and the use thereof as medicaments |
| 07/12/2006 | CN1802379A Triazolopyrimidines |
| 07/12/2006 | CN1802378A Beta-strand mimetics and method relating thereto |
| 07/12/2006 | CN1802214A Method for increasing the cutting hardness of a molded body |
| 07/12/2006 | CN1802159A 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 07/12/2006 | CN1800273A Use of marine fungus originated compounds as antifouling agents |
| 07/12/2006 | CN1800186A Adenosine a2a receptor antagonists |
| 07/12/2006 | CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes. |
| 07/12/2006 | CN1800184A Synthesis of temozolomide and analogs |
| 07/12/2006 | CN1800183A One-step synthesis process for pemetrexed disodium key intermediate |
| 07/12/2006 | CN1800169A Pemetrexed disodium key intermediate and its synthesis method, and method for synthesizing pemetrexed disodium from the said intermediate |
| 07/12/2006 | CN1263759C Improving method for preparing cross-bridge macrocylic compound |
| 07/12/2006 | CN1263758C 3,7-diazabicyclo[3,3,o] otanes and their use in treatment of cardiac arrhythmias |
| 07/12/2006 | CN1263757C Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 07/12/2006 | CN1263756C Imidazolepyrimidine derivatives and triazolopyrimidine derivatives |
| 07/12/2006 | CN1263751C Novel compounds |
| 07/11/2006 | US7074929 Certain alkylene diamine-substituted heterocycles |
| 07/11/2006 | US7074926 dissolving gases of triethylenediamine in solvents selected form acyclic alcohols-2+ or ethers of these alcohols, then treating with adsorbers such as activated carbon or ion exchangers; purification; storage stability |
| 07/11/2006 | US7074924 Compounds as cancer inhibitors in mixtures with other compounds such as methotrextrate |
| 07/11/2006 | US7074920 Process for the synthesis of 1,3-dihydro-2H-3-benzazepin-2-one compounds, and to the application thereof in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
| 07/11/2006 | US7074826 R-NSAID esters and their use |
| 07/11/2006 | US7074797 Pyrazolopyrimidines as CRF receptor antagonists |
| 07/11/2006 | US7074794 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor |
| 07/11/2006 | US7074793 KInase inhibitor; Alzheimer's disease; central nervous system disorders; antiinflamamtory agents; skin disorders; osteoporosis; atherosclerosis; restenosis; thrombosis; antidiabetic agents; viricides; fungicides |
| 07/11/2006 | US7074792 antiserotonine agents; central nervous system disorders; Alzheimer's disease |
| 07/11/2006 | US7074791 Pyrrolo[1,2-b]pyridazine compounds and their uses |
| 07/11/2006 | US7074790 Antiinflammatory agents; autoimmune disease |
| 07/11/2006 | US7074781 E.g., 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L-proline-N,N-dimethylamide; control of urinary incontinence and bleeding disorders. |
| 07/11/2006 | US7074534 Polymeric charge transport compositions and electronic devices made with such compositions |
| 07/11/2006 | CA2376876C New isoindoloindolone derivatives, the process for preparing them and the pharmaceutical compounds that contain them |
| 07/11/2006 | CA2260999C Heterocyclic compounds, their production and use in tyrosine kinase inhibition |
| 07/11/2006 | CA2246783C Mcbi analogs of cc-1065 and the duocarmycins |
| 07/11/2006 | CA2158609C 5 .alpha.-reductase inhibitors |
| 07/06/2006 | WO2006071819A1 [1h-pyrazolo[3, 4-d]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (p70s6k, atk1 and atk2) for the treatment of immunological, inflammatory and proliferative diseases |
| 07/06/2006 | WO2006071752A1 Azolopyrimidine-based inhibitors of dipeptidyl peptidase iv and methods |
| 07/06/2006 | WO2006071138A1 Tritium-traced saxitoxin dihydrochloride and method for the production thereof |